Your browser doesn't support javascript.
loading
Bayesian structural time series, an alternative to interrupted time series in the right circumstances.
Gianacas, Christopher; Liu, Bette; Kirk, Martyn; Di Tanna, Gian Luca; Belcher, Josephine; Blogg, Suzanne; Muscatello, David J.
Afiliação
  • Gianacas C; School of Population Health, University of New South Wales, Sydney, Australia; The George Institute for Global Health, University of New South Wales, Sydney, Australia; NPS MedicineWise, Sydney, Australia. Electronic address: c.gianacas@unsw.edu.au.
  • Liu B; School of Population Health, University of New South Wales, Sydney, Australia.
  • Kirk M; National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australia.
  • Di Tanna GL; The George Institute for Global Health, University of New South Wales, Sydney, Australia; Department of Business Economics, Health & Social Care (DEASS), University of Applied Sciences and Arts of Southern Switzerland (SUPSI), Lugano, Switzerland.
  • Belcher J; NPS MedicineWise, Sydney, Australia.
  • Blogg S; NPS MedicineWise, Sydney, Australia.
  • Muscatello DJ; School of Population Health, University of New South Wales, Sydney, Australia.
J Clin Epidemiol ; 163: 102-110, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37839620
OBJECTIVES: Compare two approaches to analyzing time series data-interrupted time series with segmented regression (ITS-SR) and Bayesian structural time series using the CausalImpact R package (BSTS-CI)-highlighting advantages, disadvantages, and implementation considerations. STUDY DESIGN AND SETTING: We analyzed electronic health records using each approach to estimate the antibiotic prescribing reduction associated with an educational program delivered to Australian primary care physicians between 2012 and 2017. Two outcomes were considered: antibiotics for upper respiratory tract infections (URTIs) and antibiotics of specified formulations. RESULTS: For URTI indication prescribing, average monthly prescriptions changes were estimated at -4,550; (95% confidence interval, -5,486 to -3,614) and -4,270; (95% credible interval, -5,934 to -2,626) for ITS-SR and BSTS-CI, respectively. Similarly for specified formulation prescribing, monthly average changes were estimated at -7,923; (95% confidence interval, -15,887 to 40) for ITS-SR and -20,269; (95% credible interval, -25,011 to -15,635) for BSTS-CI. CONCLUSION: Differing results between ITS-SR and BSTS-CI appear driven by divergent explanatory and outcome series trends. The BSTS-CI may be a suitable alternative to ITS-SR only if the explanatory series represent the secular trend of the outcome series before the intervention and are equally affected by exogenous or confounding factors. When appropriately applied, BSTS-CI provides an alternative to ITS with more readily interpretable Bayesian effect estimates.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Respiratórias Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Respiratórias Idioma: En Ano de publicação: 2023 Tipo de documento: Article